• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Belgium·Healthcare·MLBON.PA
Share

bonyf N.V. Stocks

€ 1.9Last Updated 21.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

€ 1.25M

€ 1.9
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

bonyf N.V. is a Belgian firm dedicated to the research, development, manufacturing, and distribution of a diverse range of oral and dental healthcare products. Its specialized offerings include PerioTabs, a brushing solution crafted for gums, teeth, and dental implants to mitigate conditions such as gingivitis, periodontitis, peri-mucositis, and peri-implantitis. Another key product is AphtoFix, a film-forming cream designed for the localized treatment of mouth ulcers. The company provides an extensive line of denture care items, featuring OlivaFix and Superior denture adhesive creams, alongside NitrAdine disinfecting denture tabs for hygiene. For repairs, bonyf offers Denture Repair-fix, an immediate solution for fractured dentures or detached teeth, and Fixobridge, a ready-to-use cement for reattaching dislodged crowns, inlays, and bridges. Complementing these are denture relining cushions for improving the fit of ill-fitting dentures, effervescent denture cleanser tabs, and Cavifix, a synthetic resin-based material for temporarily sealing new cavities and repairing lost fillings. Beyond general dental care, bonyf N.V. extends into orthodontic solutions with NitrAdine Ortho & Junior disinfecting tabs, formulated to clean and sanitize removable orthodontic appliances. Furthermore, its portfolio includes wound care products like HeelFix and FingerFix paste dressings, specifically designed to address cracked and chapped skin on the feet and hands. Established in 1979, the company's corporate headquarters are located in Gent, Belgium.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 00:38

Microsoft is cutting costs: 60,000 employees have been offered voluntary separation

27.10.2026 00:18

"If the bubble bursts, it will all start with debt": How the problems of the neo-claws threaten the S&P 500

26.10.2026 23:40

Buyers of the foldable iPhone have complained about screen damage. How does this affect the stock price?

26.10.2026 23:02

One of Wall Street’s biggest bulls drops overweight call on stocks ahead of midterms

26.10.2026 22:15

Revolut launches personal loans in the UK. What does this mean for the neobank?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026